Work

Abstract 3816: DNA variation at BARD1 predicts response to aurora kinase inhibition in neuroblastoma.

Year: 2013

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2013-3816

Authors: Vanessa M. Pineros, Kris R. Bosse, Lori S. Hart, Sharon J. Diskin, JulieAnn Rader, John M. Maris

Institutions: University of Pennsylvania, Children's Hospital of Philadelphia

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2324677455

Cites:

Cited by:

Related to: 10